0.68
price down icon4.75%   -0.0339
after-market Dopo l'orario di chiusura: .68
loading
Precedente Chiudi:
$0.7139
Aprire:
$0.7248
Volume 24 ore:
1.10M
Relative Volume:
0.69
Capitalizzazione di mercato:
$70.91M
Reddito:
$153.73M
Utile/perdita netta:
$-106.79M
Rapporto P/E:
-0.382
EPS:
-1.78
Flusso di cassa netto:
$-115.93M
1 W Prestazione:
-17.32%
1M Prestazione:
-24.25%
6M Prestazione:
-63.04%
1 anno Prestazione:
-77.70%
Intervallo 1D:
Value
$0.6736
$0.7256
Intervallo di 1 settimana:
Value
$0.6736
$0.865
Portata 52W:
Value
$0.5231
$5.17

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
Nome
Sutro Biopharma Inc
Name
Telefono
650-392-8412
Name
Indirizzo
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
Dipendente
269
Name
Cinguettio
@SutroBio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
STRO's Discussions on Twitter

Confronta STRO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
STRO
Sutro Biopharma Inc
0.68 70.91M 153.73M -106.79M -115.93M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-16 Aggiornamento Piper Sandler Neutral → Overweight
2025-03-17 Downgrade H.C. Wainwright Buy → Neutral
2025-03-14 Downgrade BofA Securities Buy → Underperform
2025-03-14 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
2025-03-14 Downgrade Wedbush Outperform → Neutral
2024-05-08 Iniziato BofA Securities Buy
2023-11-09 Iniziato Deutsche Bank Buy
2023-10-06 Iniziato Oppenheimer Outperform
2023-03-21 Downgrade Wells Fargo Overweight → Equal Weight
2022-08-18 Ripresa Wells Fargo Overweight
2021-06-18 Iniziato H.C. Wainwright Buy
2020-12-03 Iniziato Stifel Buy
2020-09-02 Iniziato Jefferies Buy
2020-07-16 Iniziato Wells Fargo Overweight
2020-01-13 Iniziato SunTrust Buy
2019-10-07 Iniziato BTIG Research Buy
2019-07-18 Iniziato Deutsche Bank Buy
2019-04-29 Iniziato H.C. Wainwright Buy
2018-10-22 Iniziato JMP Securities Mkt Outperform
2018-10-22 Iniziato Piper Jaffray Overweight
2018-10-22 Iniziato Wedbush Outperform
Mostra tutto

Sutro Biopharma Inc Borsa (STRO) Ultime notizie

pulisher
Jun 17, 2025

Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade to Overweight by Piper S - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Piper Sandler Upgrades Sutro Biopharma to Overweight From Neutral, $2 Price Target - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade with Promising Drug Prospects | STRO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Piper Sandler upgrades Sutro Biopharma stock rating on pipeline progress By Investing.com - Investing.com Canada

Jun 16, 2025
pulisher
Jun 16, 2025

Bank of America Corp DE Sells 22,894 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Analysts - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Piper Sandler Upgrades Sutro Biopharma (STRO) to Overweight | ST - GuruFocus

Jun 15, 2025
pulisher
Jun 09, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Position Decreased by Two Sigma Investments LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Millennium Management LLC - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Boosts Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Nuveen Asset Management LLC Acquires 124,154 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Sutro Biopharma names Greg Chow as new CFO - Investing.com

Jun 03, 2025
pulisher
Jun 02, 2025

Sutro Biopharma (STRO) Appoints New CFO Greg Chow | STRO Stock N - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Sutro Biopharma names Greg Chow as new CFO By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Sutro Biopharma Appoints Greg Chow as Chief Financial Officer - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Sutro Biopharma Strengthens ADC Leadership: New CFO Brings $225M Capital Raising Track Record - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Two Sigma Advisers LP Has $1.01 Million Stock Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Northern Trust Corp Buys 14,492 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 29, 2025
pulisher
May 28, 2025

BNP Paribas Financial Markets Buys 68,234 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 28, 2025
pulisher
May 27, 2025

Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes By Investing.com - Investing.com Nigeria

May 27, 2025
pulisher
May 26, 2025

Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes - Investing.com

May 26, 2025
pulisher
May 23, 2025

Sutro Biopharma unveils best-in-class anti-tissue factor ADC - BioWorld MedTech

May 23, 2025
pulisher
May 22, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Brokerages - Defense World

May 22, 2025
pulisher
May 20, 2025

Sutro Biopharma (NASDAQ:STRO) Price Target Cut to $0.80 by Analysts at Bank of America - Defense World

May 20, 2025
pulisher
May 19, 2025

Sutro Biopharma (STRO): Analyst Lowers Price Target by 20% | STR - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Bank of America Adjusts Sutro Biopharma (STRO) Price Target | ST - GuruFocus

May 19, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Buys 156,139 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

May 15, 2025
pulisher
May 14, 2025

Sutro Biopharma Reports Q1 2025 Earnings and Restructuring - TipRanks

May 14, 2025
pulisher
May 14, 2025

Transcript : Sutro Biopharma, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04 - marketscreener.com

May 14, 2025
pulisher
May 12, 2025

Sutro Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Barclays PLC - Defense World

May 12, 2025
pulisher
May 10, 2025

Sutro Biopharma Inc Reports Q1 2025 Revenue of $17.4M, Exceeding Estimates; EPS at -$0.91, Missing Projections - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts

May 09, 2025
pulisher
May 09, 2025

Sutro Biopharma earnings missed by $0.06, revenue topped estimates - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times

May 09, 2025
pulisher
May 08, 2025

Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights | STRO Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Sutro Biopharma, Inc. Advances ADC Pipeline Focus with Promising Preclinical Results and Strategic Reprioritization - Nasdaq

May 08, 2025
pulisher
May 07, 2025

Financial Metrics Check: Sutro Biopharma Inc (STRO)’s Ratios for Trailing Twelve Months - DWinneX

May 07, 2025
pulisher
May 06, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Invesco Ltd. - Defense World

May 06, 2025
pulisher
May 02, 2025

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

May 02, 2025
pulisher
May 02, 2025

Sutro Biopharma (NASDAQ:STRO) Earns Neutral Rating from HC Wainwright - The AM Reporter

May 02, 2025
pulisher
May 01, 2025

Sutro Biopharma to Participate in Upcoming Investor Conferences - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Leading ADC Developer Sutro Biopharma to Present at Citizens and BofA Healthcare Conferences in May - Stock Titan

May 01, 2025
pulisher
May 01, 2025

New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Benzinga

May 01, 2025
pulisher
May 01, 2025

Sutro Biopharma (NASDAQ:STRO) Earns “Neutral” Rating from HC Wainwright - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Taking the lead: Sutro Biopharma Inc (STRO) - Sete News

Apr 30, 2025

Sutro Biopharma Inc Azioni (STRO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Sutro Biopharma Inc Azioni (STRO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
May 01 '25
Option Exercise
0.00
37,849
0
133,282
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
May 01 '25
Option Exercise
0.00
2,500
0
54,580
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
May 01 '25
Option Exercise
0.00
69,063
0
122,161
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Apr 11 '25
Option Exercise
0.00
21,250
0
59,683
NEWELL WILLIAM J
CEO
Mar 05 '25
Option Exercise
0.00
18,750
0
299,239
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 05 '25
Option Exercise
0.00
8,750
0
99,027
ALBINI EDWARD C
CFO AND SECRETARY
Mar 05 '25
Option Exercise
0.00
8,750
0
135,675
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 04 '25
Option Exercise
0.00
9,125
0
94,025
NEWELL WILLIAM J
CEO
Mar 04 '25
Option Exercise
0.00
31,125
0
291,625
Chung Jane
PRESIDENT AND COO
Mar 04 '25
Option Exercise
0.00
7,875
0
100,642
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):